Spathis AD, Asvos X, Ziavra D, Karampelas T, Topouzis S, Cournia Z, Qing X, Alexakos P, Smits LM, Dalla C, et al. Nurr1:RXR? heterodimer activation as monotherapy for Parkinson's disease. Proc Natl Acad Sci U S A. 2017;114(15):3999-4004.